AdvanSix Inc. — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 42/100
What the filing says
AdvanSix reported Q2 2026 sales of $421.3M (+3% YoY) with diluted EPS of $0.12 vs $1.15 in Q2 2025. Net income fell 90% to $3.2M from $31.4M due to 15% volume decline in Plant Nutrients (31% of sales, down to $131.4M from $156.8M), offset partly by 18% pricing gains. Adjusted EBITDA fell 43% to $31.9M from $55.7M. H1 2026 shows net loss of $12.3M vs profit of $54.7M. Board declared $0.16/share dividend. Company reduced 2026 capex guidance to $75–95M and plant turnaround cost impact to ~$17M.
Why this rating
Significant profit decline (90% EPS drop) driven by weak agricultural end market and volume collapse in Plant Nutrients. However, absolute sales stable and pricing resilient. Capital and turnaround impacts modest vs $622M market cap. Operational headwinds meaningful but not existential.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.